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Background:  Hypothyroidism  is  a reversible  cause  of  atrioventricular  (AV)  block.  Few  reports  have
described  reversible  AV  block  caused  by hyperthyroidism.  However,  it is  unknown  whether  patients
with  AV  block  are  expected  to have  a benign  course  after the  initiation  of  appropriate  therapy  for  thyroid
dysfunction.
Methods:  The  study  group  consisted  of  patients  with  II or III degree  AV block  and bradyarrhythmia
(≤40  bpm)  excluding  patients  with  myocardial  infarction,  electrolyte  abnormalities,  digitalis  toxicity,
and  vasovagal  syncope.  Thyroid  dysfunction  is  diagnosed  when  thyroid  stimulating  hormone  and  thy-
roxine  levels  are not  in deﬁned  normal  ranges.  AV  block  was  determined  by surface  electrocardiogram
(ECG).  The  cause  and  effect  relation  between  AV  block  and  thyroid  dysfunction  was  evaluated.
Results:  Of  668  patients,  29  (4.3%)  had  hypothyroidism  (19 overt)  and  21  (3.1%)  had  hyperthyroidism  (8
overt). The  most  frequent  ECG  ﬁnding  was  complete  AV block  (27 of  50  patients).  Ten patients  had  brad-
yarrhythmia  and  13  had  second-degree  AV  block.  Euthyroid  state  was  achieved  in  10 hypothyroidic  (34%)
and  in  7 hyperthyroidic  patients  (33%)  with  hormone  replacement  and  antithyroid  therapy,  respectively,
during  the  follow-up  period  (≤21  days).  Thyroid  dysfunction  was  found  to be not related  with  AV  block
in  40  patients  (80%).  However,  in 4  of  10 patients  with  AV  block  related  to thyroid  dysfunction  the  reso-
lution  of AV  block  occurred  after  the  placement  of  pacemaker  (>21  days).  Overall,  44  of  50  (88%) patients
with  AV  block  in association  with  thyroid  dysfunction  were  implanted  with  a  permanent  pacemaker.  Of
6  patients  who  did  not  receive  a pacemaker,  2 had  complete  AV  block  and  4 had  bradyarrythmia.
Conclusion:  AV block  associated  with  thyroid  dysfunction  needs  great  attention  regardless  of type of  the
thyroid  disease.  Patients  with  II and/or  III degree  AV  block  in  the  setting  of  thyroid  dysfunction  almost
always  need  permanent  pacemaker  insertion  even  after  normalization  of  thyroid  status.
2  Jap© 201
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Hypothyroidism is not an uncommon cause of complete atri-
ventricular (AV) block in clinical practice. Also, hyperthyroidism
s thought to be a reversible cause of AV block [1–3]. According to
ontemporaneous guidelines pacemaker implantation is generally
onsidered unnecessary in patients with “thyroid dysfunction asso-
iated with AV block” (TDAB) [4]. However, it is not known whether
atients with TDAB can expect a benign course after the initiation of
ppropriate medical therapy. Moreover, the time course between
he initial therapy for thyroid dysfunction and recovery of AV block
s not clear. Hence, the appropriate strategy for patients with AV
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block in association with thyroid dysfunction remains challeng-
ing for physicians. We  examined the clinical course of consecutive
patients admitted to our institution with the diagnosis of “AV block”
and hypo/hyperthyroidism.
Methods
We  reviewed patients who  had second-degree or third-degree
AV block, and bradyarrhythmia (average heart rate ≤40 bpm on 24-
h Holter monitoring) from our institution between January 2008
and June 2009. In addition, using the same criteria for patient
selection, we collected patients prospectively beginning from June
2009. Shortly, all hospitalized patients to the department of cardi-
ology with symptomatic AV block between January 2008 and July
2010 were evaluated. Patients with concomitant myocardial infarc-
tion, electrolyte abnormalities, digitalis toxicity, and vasovagal
vier Ltd. All rights reserved.
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Table 1
Classiﬁcation of second- or third-degree AV block and bradyarrhythmia based upon electrocardiographic characteristics.
AV-nodal block Infranodal AV block Undetermined level of AV block
Second-degree AV block PR increment preceding a blocked
P  (Wenckebach) and narrow QRS
Constant PR interval preceding
blocked P
PR increment (Wenckebach)
preceding a blocked P and wide
QRS
Third-degree AV block Escape rhythm has narrow QRS
and rate ≥40 beats/min
Escape rhythm has wide QRS
and rate <40 beats/min
Escape rhythm has wide QRS and
rate ≥40 beats/min
Bradyarrhythmia f waves with irregular narrow QRS f waves with regular wide QRS f waves with irregular wide QRS
AV, atrioventricular; f, ﬁbrillatory.
Table 2
The level of AV block based upon the surface electrocardiographic ﬁndings in patients with thyroid dysfunction.
Subclinical hypothyroidism Subclinical hyperthyroidism Overt hypothyroidism Overt hyperthyroidism p
n  (%) n (%) n (%) n (%)
AV-Nodal 4 (40) 8 (61.5) 7 (36.8) 4 (50) 0.568
Infranodal 4 (40) 3 (23.1) 11 (57.9) 3 (37.5)
Undetermined 2 (20) 2 (15.4) 1 (5.3) 1 (12.5)
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V, atrioventricular.
yncope were excluded. Also, patients who were taking beta-
lockers, nondihydropyridine calcium-channel blockers, and class
 and III antiarhythmics were excluded from this study. Thy-
otropin (thyroid stimulating hormone, TSH) and thyroxin levels
ere studied from all hospitalized patients with AV block. Thyroid
ysfunction was deﬁned according to the value of the TSH and thy-
oxin. TSH level above the normal range (≥5 mIU/L), with or without
hyroxin depletion (<2 ng/L) was deﬁned as overt or subclinical
ypothyroidism, respectively. Decreased level of TSH (<1 mIU/L),
ith or without elevated thyroxin (>5 ng/L) level was  deﬁned as
vert or subclinical hyperthyroidism, respectively. Etiology of thy-
oid dysfunction was not sought for inclusion or exclusion. Patients
ho were on treatment for thyroid dysfunction before admission
ith AV block are classiﬁed as hypo or hyperthyroidic, according
o their previous diagnosis irrespective of the level of TSH during
he index hospitalization. All of the patients with abnormal TSH
evel were consulted by the endocrinologist and appropriate treat-
ent with antithyroid medication or hormone supplementation
ave been started in hospital. Twelve of 29 hypothyroidic and 2 of
1 hyperthyroidic patients had been treated before the admission
ith AV block, and they all had normal TSH value during admission.
ermanent pacemaker was implanted to all of the patients who  had
een treated for thyroid dysfunction before the admission with AV
lock.
The type and level of AV block were determined by the surface
lectrocardiogram (ECG) [5–9] (Table 1). Patients were classiﬁed
nto two groups to deﬁne a relationship between thyroid dysfunc-
ion and AV block: (1) AV block related to thyroid dysfunction:
DAB that resolved after the appropriate treatment and did not
ecur during the follow-up period (≤21 days); (2) AV block not
elated to thyroid dysfunction-incidental block (IB): AV block that
ever resolved within 3 weeks after initiation of medication or
esolved but relapsed in spite of continuation of the therapy and
ormalization of TSH level. All patients were monitored contin-
ously until they had improved AV conduction or received an
mplanted pacemaker. If AV block did not resolve within 4–6 days
 pacemaker implantation was decided. Patients with resolved AV
lock were followed in hospital up to 3 weeks. Recurrent cases
ere identiﬁed by routine ECG that was obtained twice a day or by
CG that was obtained in case of bradycardia-related symptoms.
ermanent pacemaker was implanted for all of the patients with
ecurrence of AV block during follow-up. Patients who recovered
pparent normal AV conduction after normalization of the thy-
oid status were recommended to visit arrhythmia polyclinic, forively.
evaluation of AV conduction with surface ECG, within one month
after discharge. Patients who had abnormal TSH level at the time
of pacemaker placement have been followed until they had normal
TSH level to reveal the exact relation between the thyroid dysfunc-
tion and an AV block. Patients with improved AV conduction and
no pacemaker dependency at pace rate of 40 bpm were classiﬁed as
an AV block related to thyroid dysfunction. Those who had persis-
tent AV block and/or pacemaker dependency at pace rate ≤40 bpm
were deﬁned as IB. Collection and analyses of data were authorized
by the ethics committee of the hospital.
Statistical analysis
Quantitative variables were expressed as mean value ± SD, and
qualitative variables were expressed as percent (%). Categorical
data were compared using the Chi-square test or Fisher’s exact
test. Logistic analysis was applied for multivariate analysis. A p-
value < 0.05 was  considered statistically signiﬁcant. All statistical
studies were carried out using NCSS 2007 (Number Cruncher Sta-
tistical System) and PASS 2008 Statistical Software Program (NCSS,
Kaysville, UT, USA).
Results
Among the 668 study patients (mean age 68.2 ± 15.4 years, 337
women), 50 patients (7.4%) had the diagnosis of thyroid dysfunc-
tion during the hospitalization for AV block. Of these 19 patients
(2.8%) had overt hypothyroidism (mean age 67.73 ± 9.04 years,
17 women), 8 patients (1.1%) had overt hyperthyoidism (mean
age 67.75 ± 11.27 years, 6 women), 10 patients (1.4%) had sub-
clinical hypothyroidism (mean age 69.10 ± 11.10 years, 4 women),
and 13 patients (1.9%) had subclinical hyperthyroidism (mean age
71.92 ± 15.56 years, 9 women). In 36 of 50 (72%) patients with thy-
roid dysfunction, the diagnosis was  established during the index
hospitalization. The AV block type was  similar in all four subclini-
cal or overt hypo/hyperthyroidism groups (Table 2). Although there
was no effect of comorbidities on the reversibility of AV block, dia-
betes mellitus and hypertension were common in patients with
hypothyroidism (Table 3).TSH level was normalized in 10 patients with hypothyroidism
after the hormone supplementation therapy. While, AV block was
resolved and never recurred in 5 patients, 3 patients had sus-
tained AV block and 2 patients had recurrence of AV block despite
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Table  3
Major comorbidities in patients with thyroid dysfunction.
Thyroid dysfunction p
Hypothyroidism Hyperthyroidism
n (%) n (%)
DM 12 (41.4%) 3 (14.3%) 0.039*
HT 22 (75.9%) 10 (47.6%) 0.040*
CRF 3 (10.3%) 2 (9.5%) 1.000
Mean values (SD) and % (n) are reported for continuous and categorical variables, respectively.
CRF: chronic renal failure; DM:  diabetes mellitus; HT: hypertension.
* p < 0.05.
Fig. 1. Clinical course in patients with atrioventricular (AV) block and hypothyroidism. AV conduction was improved and never recurred in 5 patients with normalized thyroid
stimulating hormone (TSH) level after the hormone supplementation therapy during the follow-up period (≤21 days). Any patient with abnormal TSH level experienced AV
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londuction improvement during the follow-up period. Extended follow-up of these
he continuation of therapy (Fig. 1). A permanent pacemaker was
mplanted for these ﬁve patients. Euthyroid state was achieved
n 7 of 21 patients with hyperthyroidism with the antithyroid
herapy, but AV block was resolved in only 3 of them. However,
 out of these 3 patients experienced recurrence of AV block,
nd remaining 4 patients had sustained AV block. As a result 6
f 7 hyperthyroidic patients who achieved euthyroid state had
mplanted a pacemaker (Fig. 2). Seven patients with hypothy-
oidism and 12 patients with hyperthyroidism had abnormal TSH
evel while implanting a pacemaker. Overall 24 of 29 hypothyroidicnts revealed two additional AV blocks related to hypothyroidism.
and 20 of 21 hyperthyroidic patients with AV block underwent a
permanent pacemaker placement. However, 4 out of 44 pacemaker
implanted patients were detected as having AV block secondary to
thyroid dysfunction according to the extended follow-up with the
ECG, TSH level, and device’s memories. In these 4 patients two had
AV block related to hypothyroidism and two related to hyperthy-
roidism (Figs. 1 and 2).
In conclusion, only 7 (24%) patients with hypothyroidism and
just 3 (14%) patients with hyperthyroidism have had an AV block
secondary to the thyroid disease. AV block in association with
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Fig. 2. Clinical course in patients with atrioventricular (AV) block and hyperthyroidism. AV conduction was  improved and never recurred in only one patient with normalized
thyroid-stimulating hormone (TSH) level after the antithyroid therapy during the follow-up period (≤21 days). Any patient with abnormal TSH level experienced AV conduction
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hyroid dysfunction was not suggested as being secondary to the
isease in 40 of 50 patients (80%).
iscussion
Thyroid hormone exerts a major inﬂuence on the cardiovas-
ular system by a number of direct and indirect mechanisms
nd, not surprisingly, its cardiovascular effects are prominent in
oth hypothyroidism and hyperthyroidism. It has direct inotropic,
hronotropic, and dromotropic effects that are similar to those seen
ith adrenergic stimulation such as tachycardia and increased car-
iac output [10].
Conduction block from the atrium to the ventricle may  occur
ecause of various reasons in a number of clinical situations. The
tiologies may  be classiﬁed as functional or structural. Those that
re functional (metabolic disorders including hypothyroidism) are
tated to be reversible in textbooks of internal medicine [11]. How-
ver, the association of disturbances of intracardiac conduction
ith adult hypothyroidism is not well known. To our knowledge,
he rate of resolution of AV block with hormone supplemen-
ation therapy in hypothyroidic patients has not been studied
efore. In the literature, there are some case reports of improved two  additional AV blocks related to hyperthyroidism.
AV block with the normalization of TSH level after treatment of
hypothyroidism. Schoenmakers et al. reported an elderly woman
with complete AV block due to severe hypothyroidism which was
resolved after supplementation therapy with levothyroxine [12].
Reversible AV block in association with myxedema was  also pre-
sented in the literature as a case report [13]. It is postulated to be
caused by edema by compressing on AV node and levothyroxine is
thought to have an indirect effect on improving AV conduction by
resolving edema. Not only overt hypothyroidism but also subclini-
cal hypothyroidism is reported to be a possible cause of reversible
AV block. Nakayama et al. reported a middle-aged man  with tran-
sient 2/1 AV block and subclinical hypothyroidism. A conduction
disturbance was improved completely after two weeks of thyroxine
supplementation [14]. A case of AV block induced by hypothy-
roidism complicating long-term therapy with amiodarone was
reported by Mangiardi et al. [15]. Although amiodarone-induced
hypothyroidism might cause AV block, the amiodarone itself could
cause conduction defect by directly affecting cardiac conduction
system [16]. As stated above, all forms of hypothyroidism could
cause an AV block which may  resolve with levothyroxine ther-
apy. Hence, herein all patients with hypothyroidism irrespective
of primary etiology were included.
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Since, there is no obvious study to conﬁrm a levothyroxine
s the drug of hypothyroidism-related AV block, it is challeng-
ng for clinicians to manage patients with AV block in association
ith hypothyroidism. The question “Does the hormone supple-
entation improve both the AV conduction and hypothyroidism?”
emains controversial. In one study from Lardoux et al., 14 of 42
on-treated hypothyroidic patients had conduction disturbances
n routine ECG evaluation, and there was no evident effect of hor-
one therapy on conduction disturbances [17].
Since in our research hypothroidism was detected in 4.3% of
ll patients with AV block which is similar to the ratio of hypothy-
oidism in the general population, it can be postulated that AV block
oes not have increased incidence in patients with hypothyroidism
18]. Additionally, the resolution of AV block occurred in only 24%
f hypothyroidic patients despite the treatment with levothyroxine
nd normalization of TSH. These ﬁndings are distinct and con-
roversial to the general belief that “AV block in association with
ypothyroidism is reversible”.
Cardiovascular manifestations are frequent in hyperthyroidism
nd, it is commonly associated with sinus tachycardia and atrial
brillation. A rare complication of thyrotoxicosis is impaired AV
onduction [2,19–24]. Complete AV block associated with thyro-
oxicosis has generally been seen in patients with additional risk
actors such as infectious diseases [21], rheumatic fever [19], hyper-
alcemia [24], or digitalis treatment. Although complete heart block
s usually the result of the primary insult, thyrotoxicosis may
ggravate the condition. On the other hand, in the literature some
atients with AV block are reported to have thyrotoxicosis as their
nly underlying disease, and in these patients control of thyroid
isease has restored the normal AV conduction [22,23,25,26]. A 53-
ear-old woman with Graves’ disease while being euthyroid with
ropylthiourasil therapy was reported to have second-degree AV
lock and, the authors hypothesized that the most likely mech-
nism was an autoimmune response causing inﬁltration of the
ardiac conduction pathways [27]. Almange et al. suggested that
 direct effect of thyroid hormone on the myocardium was  respon-
ible for a conduction disturbance [28]. The autonomic nervous
ystem is also postulated to act by reciprocal excitation and exac-
rbate patent or latent hypervagatonia that was  preexistent to
he hyperthyroidism under the inﬂuence of thyroid hormone in
xcessive amount [26]. Complete AV block may even develop in
 patient with thyrotoxicosis occurring during thyroid hormone
herapy for clinical hypothyroidism [29]. As mentioned above, in
his report only 3 of 21 patients with hyperthyroidism-associated
V block returned to normal sinus rhythm with medical therapy.
owever pacemaker implantation was done in 2 of these patients
ue to persistency of AV block more than 6 days after the initia-
ion of therapy. In these 2 patients, ventricular stimulation based
pon devices’ memories occurred only 8% and 15% of the time.
e  assume that stimulation occurred in the initial several weeks
f pacemaker implantation and/or at nights if heart rate dropped
elow the device’s stimulation lower-rate.
tudy limitations
We  evaluated elderly symptomatic patients who  were hos-
italized. Our observations cannot be generalized to ambulatory
r younger patients with asymptomatic AV block. An AV block
s generally detected by the surface ECG, but sometimes espe-
ially in paroxysmal or intermettent AV block it is difﬁcult to
etect the block even by 24-h Holter monitoring [30]. In our study,
he surface ECG was used to detect AV block, although patients
ith paroxysmal or intermittent nature of block may  possibly be
nderdiagnosed. Although, there were reports of improved AV con-
uction after six weeks of therapy for hypo/hyperthyroidism, we
nvestigated over a relatively short time (≤21 days) to detect AV
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nodal conductance changes in period of normalization of TSH lev-
els, hence the effect of thyroid disease on AV conduction might be
underestimated. Inclusion of patients with bradyarrythmia might
be inappropriate because of the close relation between thyroid
hormone and heart rate response. Irrespective of the accuracy
of electrocardiographic characteristics in deﬁning the level of AV
block, electrophysiologic studying was  not performed in our series.
Clinical implications
Hypothyroidism is usually associated with bradycardia, and AV
block occurring in patients with such a disorder is thought to be
reversible and curable with levothyroxine therapy. Our ﬁndings
suggest that a hypothyroidism-related AV conduction disease is
really caused by hormone insufﬁciency in less than one quarter
of patients. Patients with symptomatic AV block and either overt
or subclinical hyperthyroidism almost always need a permanent
pacemaker. We  studied a small number of patients and our ﬁnd-
ings are preliminary. The results must be conﬁrmed with ﬁndings
that will be obtained from large populations in the future. One can
argue that if AV block is not improved by the treatment of thy-
roid dysfunction, there are two possibilities; no relation to thyroid
dysfunction or irreversible damage induced by the disease. How-
ever, deﬁning the exact cause of irreversible AV block is not of
clinical importance because a pacemaker should be placed in both
situations.
Conﬂicts of interest
The authors declared no conﬂicts of interest with respect to the
authorship and/or publication of this article.
References
[1] Kramer MR,  Shilo S, Hershko S. Atrioventricular and sinoatrial block in thyro-
toxic crisis. Br Heart J 1985;54:600–2.
[2] Topaloglu S, Topaloglu O, Ozdemir O, Soylu M,  Demir AD, Korkmaz S. Hyper-
thyroidism and complete atrioventricular block: a report of 2 cases with
electrophysiologic assessment. Angiology 2005;56:217.
[3]  Karakas¸ CY, Topalog˘lu C, Canbolant E, Seyfeli E, Akgül F. Hyperthyroidism as a
rare  cause of complete AV block. Thyroid 2008;18:1329–31.
[4] Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NA, Freedman RA, Gettes
LS,  Gillinov AM,  Gregoratos G, Hammill SC, Hayes DL, Hlatky MA,  Newby LK,
Page RL, Schoenfeld MH,  Silka MJ,  et al. ACC/AHA/HRS 2008 guidelines for
device-based therapy of cardiac rhythm abnormalities: a report of the Amer-
ican College of Cardiology/American Heart Association Task Force on Practice
Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline
Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices)
developed in collaboration with the American Association for Thoracic Surgery
and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1–62.
[5]  Rosen KM, Gunnar RM,  Rahimtoola SH. Site and type of second degree AV block.
Chest 1972;61:99–100.
[6] Olgin JE, Zipes DP. Speciﬁc arrhythmias: diagnosis and treatment. In: Braun-
wald E, Libby P, Bonow RO, Mann DL, Zipes DP, editors. Heart disease. A
textbook of cardiovascular medicine. 8th ed. Philadelphia: WB  Saunders; 2008.
p.  914–21.
[7] Narula OS, Samet P, Wenckebach, Mobitz type II. AV block due to block within
the His bundle and bundle branches. Circulation 1970;41:947–65.
[8] Chung EK. His bundle electrocardiography and other electrophysiologic stud-
ies. In: Chung EK, editor. Electrocardiography. Practical applications with
vectorial principles. 3rd ed. Norwalk: Appletion-Century-Crofts; 1985. p.
370–87.
[9] Langerdorf R, Cohen H, Gozo EG. Observations on second degree atrioventric-
ular block, including new criteria fort the differential diagnosis between type I
and  type II block. Am J Cardiol 1972;29:111–9.
10] Awtry EH, Colluci WS.  Disorders of the cardiovascular system: cardiac man-
ifestations of systemic disease. In: Fauci AS, Braunwald E, Kasper DL, Hauser
SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal
medicine. 17th ed. New York: McGraw Hill; 2008. p. 1498–501.
11]  Tomaselli GE. Disorders of the cardiovascular system: the bradyarhythmias. In:
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J,
editors. Harrison’s principles of internal medicine. 17th ed. New York: McGraw
Hill; 2008. p. 1416–24.
12] Schoenmakers N, de Graaff WE,  Peters RH. Hypothyroidism as the cause of
atrioventricular block in an elderly patient. Neth Heart J 2008;16:57–9.
3 f Card
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[32 K.S. Ozcan et al. / Journal o
13]  Singh JB, Starobin OE, Guerrant RL, Manders EK. Reversible atrioventricular
block in myxedema. Chest 1973;63:582–5.
14] Nakayama Y, Ohno M,  Yonemura S, Uozumi H, Kobayakawa N, Fukushima K,
Takeuchi H, Aoyagi T. A case of transient 2:1 atrioventricular block, resolved by
thyroxine supplementation for subclinical hypothyroidism. Pacing Clin Elec-
trophysiol 2006;29:106–8.
15] Mangiardi L, Gaita F, Brun S, Presbitero P, Nademanee K, Singh BN. Atrioven-
tricular block complicating amiodarone-induced hypothyroidism in a patient
with  pre-excitation and rate-dependent bilateral bundle branch block. J Am
Coll Cardiol 1986;7:180–4.
16] Kawabata M,  Hirao K, Hachiya H, Higuchi K, Tanaka Y, Yagishita A, Inaba O, Isobe
M. Role of oral amiodarone in patients with atrial ﬁbrillation and congestive
heart failure. J Cardiol 2011;58:108–15.
17] Lardoux H, Cénac A, Perlemuter L, Bernheim R, Hazard J. Disorders of intra-
cardiac conduction and hypothyroidism in adults. A systematic study of 42
cases. Nouv Presse Med  1975;4:1859–62.
18] Jameson JL. Endocrinology and metabolism: principles of endocrinology. In:
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J,
editors. Harrison’s principles of internal medicine. 17th ed. New York: McGraw
Hill; 2008. p. 2187–95.
19] Stern MP,  Jacobs RL, Duncan GW.  Complete heart block complicating hyper-
thyroidism. JAMA 1970;212:488–90.
20] Rosenblum R, Delman AJ. First degree heart block associated with thyrotoxico-
sis. Arch Intern Med 1963;112:488–90.
[
[iology 60 (2012) 327–332
21] Davis AC, Smith HL. Complete heart block in hyperthyroidism following acute
infections: a report of 6 cases with necropsy ﬁndings in 1 case. Am Heart J
1933;9:81–9.
22] Muggia AL, Stejernholm M, Houle T. Complete heart block with thyrotoxic
myocarditis. N Engl J Med  1970;283:1099–100.
23] Campus S, Rappelli A, Malavasi A, Satta A. Heart block and hyperthyroidism.
Arch Intern Med  1975;135:1091–5.
24] Sataline L, Donaghue G. Hypercalcemia, heart block and hyperthyroidism (let-
ter).  JAMA 1970;213:1342.
25] Kramer MR, Shilo S, Hershko C. Atrioventricular and sinoatrial block in thyro-
toxic crisis. Br Heart J 1985;54:600–2.
26] Toloune F, Boukili A, Ghaﬁr D, Hadri L, Chaari J, Akheddiou B, Ohayon V,
Archane MI.  Hyperthyroidism and atrioventricular block. Pathogenic hypothe-
sis.  Apropos of case and review of the literature. Arch Mal Coeur Vaiss 1988;81:
1131–5.
27] Singer Y, Shvartzman P. Second-degree atrioventricular block in Graves’ dis-
ease. Harefuah 1999;136:28–9.
28] Almange C, Turnel F, Badoual P, Murie N, Leborgne P. Hyperthyroidism and
atrioventricular heart block. Sem Hop 1978;54:1433–6.29] Eraker SA, Wickamasekaran R, Goldman S. Complete heart block with hyper-
thyroidism. JAMA 1978;239:1644–6.
30] Minamiguchi H, Nanto S, Onishi T, Watanabe T, Uematsu M,  Komuro I. Low
atrial septal pacing with dual-chamber pacemakers reduces atrial ﬁbrillation
in  sick sinus syndrome. J Cardiol 2011;57:223–30.
